Highlights Hangzhou Alltest Biotech Co., Ltd.

Equities

688606

CNE1000053G6

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 28/05/2024 BST			5-day change	1st Jan Change
56.91 ^CNY	+0.49%		-0.04%	-17.04%

04-29	China, HK stocks rise, led by property shares	RE
04-26	Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

China, HK stocks rise, led by property shares	04-29	RE
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-26	CI
Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023.	02-23	CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23	CI
Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback announced on August 17, 2023, has closed with 1,030,000 shares, representing 1.32% for CNY 59.58 million.	02-22	CI
Hangzhou Alltest Biotech Co., Ltd. agreed to acquire an unknown stake in Hangzhou Weisibo Medical Technology Co., Ltd.	01-05	CI
Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023.	01-02	CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023.	10/10/23	CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
Hangzhou Alltest Biotech Co., Ltd. announces an Equity Buyback for CNY 60 million worth of its shares.	16/08/23	CI
Hangzhou Alltest Biotech Co., Ltd. authorizes a Buyback Plan.	15/08/23	CI
Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback announced on July 22, 2022, has expired.	20/07/23	CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	29/04/23	CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23	CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22	CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/08/22	CI
Atomo Diagnostics Limited Signs Agreement with Hangzhou Alltest Biotech Co., Ltd, for Supply of A Covid-19 1 Rapid Antigen Self-Test in the Australian and New Zealand Markets	22/08/22	CI
Hangzhou Alltest Biotech Co., Ltd. announces an Equity Buyback for CNY 115.5 million worth of its shares.	22/07/22	CI
Hangzhou Alltest Biotech Co., Ltd. authorizes a Buyback Plan.	21/07/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Hangzhou Alltest Biotech Co., Ltd.

Equities

688606

CNE1000053G6

Highlights

Filters